Long-term Effects of ADHD Medication on Autistic Traits

Plain-language summary

Research suggests that while some studies explore ADHD medication in general populations or investigate autism diagnosis and treatment broadly, there isn't a clear consensus from these specific studies on the long-term effects of ADHD medication specifically on core autistic traits and overall functioning in individuals with autism. Some studies provided are not directly relevant to the question, and one relevant study is an observational study, which can show associations but doesn't prove cause and effect.

Key findings

• One observational study followed children and adolescents with ADHD over two years to assess core symptoms, daily functioning, and other conditions, which may offer some insight into long-term medication effects on functioning, though not specifically in individuals with autism.
• A meta-analysis investigated the link between acetaminophen exposure (both before and after birth) and symptoms of autism and ADHD, which is not directly related to the long-term effects of ADHD medication.
• Another review explored recent advancements in the diagnosis and treatment of Autism Spectrum Disorder (ASD), providing a general overview rather than specific long-term medication effects.
• Other studies focused on the development of cognitive functions in children and adolescents receiving long-term ADHD medication or the role of artificial intelligence in psychiatry, neither of which directly address the long-term impact of ADHD medication on autistic traits.

Studies cited (7)

1. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts — Alemany S, Avella-García C, Liew Z (2021, European journal of epidemiology, meta-analysis)

   DOI: 10.1007/s10654-021-00754-4 PMCID: PMC8542535

2. Advances in the Diagnosis and Treatment of Autism Spectrum Disorders in Children — Lin X, Wang G, Shen S (2024, Alternative therapies in health and medicine, rct)

   OBJECTIVE: This study aims to review recent developments in the diagnosis and treatment of Autism Spectrum Disorder (ASD )and provide insights for its clinical management. METHODS: The literatures were researched fro the pubmed, Wanfang and CNKI. We searched for research on the etiology, pathogenesis, diagnosis (screening and evaluation), and treatment of Autism spectrum disorder. When selecting papers to be included, priority should be given to randomized clinical trials, systematic evaluations, meta-analyses, clinical practice guidelines, and articles related to general medical readers. RESU

3. Long-term medication for ADHD (LMA) trial: 2-year prospective observational study in children and adolescents. Core symptoms, daily functioning, and comorbidity outcomes — Johnson M, Johnels JÅ, Östlund S (2024, European archives of psychiatry and clinical neuroscience, observational)

   DOI: 10.1007/s00406-023-01744-1 PMCID: PMC11127865

4. Artificial intelligence in psychiatry research, diagnosis, and therapy — Sun J, Dong QX, Wang SW (2023, Asian journal of psychiatry, other)

   DOI: 10.1016/j.ajp.2023.103705

5. Long-term medication for ADHD and development of cognitive functions in children and adolescents — Johnson M, Åsberg Johnels J, Östlund S (2021, Journal of psychiatric research, other)

   DOI: 10.1016/j.jpsychires.2021.07.055

6. Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women — Young S, Adamo N, Ásgeirsdóttir BB (2020, BMC psychiatry, other)

   DOI: 10.1186/s12888-020-02707-9 PMCID: PMC7422602

7. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder — Maras A, Schroder CM, Malow BA (2018, Journal of child and adolescent psychopharmacology, other)

   DOI: 10.1089/cap.2018.0020 PMCID: PMC6306655